Weight Loss & Metabolic Health

Retatrutide

A next-generation triple-agonist peptide for powerful weight loss, appetite control, and metabolic health.

Doctor-Prescribed

Lab-Tested Purity

Ships to Your Door

Satisfaction Guarantee

$520.00 (vial)

Select Dosage:

Promotes significant, clinically backed weight loss

Improves glucose regulation and insulin sensitivity

Reduces appetite and enhances satiety

Increases fat burning and overall energy expenditure

Supports cardiovascular and metabolic wellness

What is Retatrutide?

Retatrutide is a groundbreaking investigational peptide that functions as a triple receptor agonist, activating GLP-1, GIP, and glucagon receptors simultaneously. This multi-pathway action makes it one of the most advanced metabolic peptides in research today — showing superior outcomes in weight reduction, glucose control, and overall metabolic optimization compared to single or dual-agonist therapies. Early studies demonstrate that Retatrutide may deliver greater fat loss and metabolic improvement than existing GLP-1 agents like semaglutide or tirzepatide, making it a potential next-generation solution for obesity, insulin resistance, and metabolic syndrome. At PeptideWebMD, Retatrutide therapy is prescribed through a doctor-supervised telehealth consultation, ensuring optimal dosing, safety, and sustainable results tailored to individual metabolic goals.

Note: This product is not approved by the FDA. It is available only via prescription under the supervision of a licensed healthcare provider.

Science & Mechanism of Action

Retatrutide’s triple-agonist mechanism uniquely combines the benefits of three critical hormone pathways: Together, these actions replicate a comprehensive hormonal response to food intake — balancing glucose, reducing fat storage, and accelerating weight loss through sustained metabolic activation.

GLP-1 Receptor Activation

Enhances insulin secretion, slows gastric emptying, and suppresses appetite.

GIP Receptor Activation

Improves glucose tolerance and energy metabolism.

Glucagon Receptor Activation

Stimulates fat oxidation and increases resting energy expenditure.

Benefits & Clinical Applications

Scientifically supported benefits across multiple health concerns

For Weight Management

Achieve greater fat loss compared to GLP-1 or dual-agonist peptides
Suppresses appetite and reduces cravings
Maintains lean muscle mass during weight loss

For Metabolic Health

Improves insulin sensitivity and glycemic control
Reduces cholesterol and triglycerides
May lower blood pressure and inflammatory markers

For Long-Term Wellness

Supports energy regulation and fat oxidation
May benefit non-alcoholic fatty liver disease (NAFLD) models
Contributes to overall cardiometabolic resilience

Physician-Guided Protocol

Safe, effective dosing under medical supervision

For educational reference only. Actual dosing is determined by your licensed PeptideWebMD physician.

Typical Treatment Protocol

Delivery Method

Subcutaneous injection, once weekly

Typical Range

2 mg – 12 mg weekly, adjusted based on tolerance and outcomes

Duration

ypically used in long-term metabolic protocols under medical supervision

Note: All protocols are prescribed and monitored by licensed physicians. Dosing varies based on individual needs, injury severity, and treatment goals. Do not self-administer without medical guidance.

Safety Profile & Considerations

Transparent information about side effects and contraindications

Common Side Effects

Temporary nausea, mild gastrointestinal discomfort, or reduced appetite during early stages of therapy.

Who Should Avoid

Avoid use in individuals with a history of pancreatitis or thyroid C-cell tumors (as per GLP-1 class guidelines).
Patients using insulin or oral hypoglycemics should be monitored closely to prevent hypoglycemia.

Retatrutide represents the next evolution in metabolic therapy — addressing not just appetite or glucose, but the entire energy balance system. The triple-receptor synergy offers unmatched potential for long-term, sustainable weight and health improvements.

Dr. Jonathan Hinds, MD, FAAMFM, ABAARM Medical Director, PeptideWebMD

Frequently Asked Questions

Common questions about Retatrutide

How does Retatrutide differ from Semaglutide or Tirzepatide? +

Retatrutide activates three receptors — GLP-1, GIP, and glucagon — while Semaglutide targets GLP-1 alone and Tirzepatide targets GLP-1 and GIP. This triple-agonist design produces deeper fat loss and metabolic benefits.

Is Retatrutide only for weight loss? +

No. It is also being studied for type 2 diabetes, fatty liver disease, and cardiovascular health.

When are results typically seen? +

Clinical data suggest measurable improvements in weight and blood glucose within 8–12 weeks, with continued benefits over several months.

Can it be used with other peptides? +

Yes. Under medical supervision, Retatrutide can be combined with mitochondrial and fat metabolism peptides for enhanced results.